PapersFlow Research Brief

Obstructive Sleep Apnea Research
Research Guide

What is Obstructive Sleep Apnea Research?

Obstructive Sleep Apnea Research is the scientific investigation into the causes, prevalence, diagnosis, measurement standards, and health consequences of obstructive sleep apnea, a sleep disorder characterized by recurrent upper airway obstruction during sleep.

Obstructive Sleep Apnea Research encompasses over 109,766 published works focused on epidemiology, diagnostic tools, and clinical outcomes. Key contributions include the Epworth Sleepiness Scale for measuring daytime sleepiness, introduced by Murray W. Johns (1991), and standardized scoring rules for respiratory events from the American Academy of Sleep Medicine. Population studies, such as those by Terry Young et al. (1993), established high prevalence rates of sleep-disordered breathing among middle-aged adults.

109.8K
Papers
N/A
5yr Growth
1.8M
Total Citations

Research Sub-Topics

Why It Matters

Obstructive Sleep Apnea Research identifies risks like hypertension and cardiovascular disease, informing treatments such as continuous positive airway pressure (CPAP). Paul E. Peppard et al. (2000) demonstrated a dose-response association between sleep-disordered breathing and hypertension four years later, independent of confounders, affecting millions globally. José M. Marın et al. (2005) showed untreated obstructive sleep apnoea-hypopnoea increased long-term cardiovascular mortality in men, reduced by CPAP. Recent developments include a sleep apnea pill trial with 646 participants by Apnimed and an $80 million financing for Mosanna Therapeutics' nasal spray, alongside UCSD trials exploring CPAP, eszopiclone, and oxygen responses.

Reading Guide

Where to Start

"Epidemiology of Obstructive Sleep Apnea" by Terry Young, Paul E. Peppard, Daniel J. Gottlieb (2002) provides foundational population-based evidence on prevalence and morbidity, ideal for beginners before diving into diagnostics or outcomes.

Key Papers Explained

Murray W. Johns (1991) introduced the Epworth Sleepiness Scale for daytime sleepiness measurement, foundational for symptom assessment. Terry Young et al. (1993) established prevalence of sleep-disordered breathing, building the epidemiological base cited in Terry Young et al. (2002)'s comprehensive epidemiology review. Paul E. Peppard et al. (2000) linked this to hypertension risks, while José M. Marın et al. (2005) extended to cardiovascular outcomes with CPAP effects, connecting symptoms to long-term health impacts.

Paper Timeline

100%
graph LR P0["A New Method for Measuring Dayti...
1991 · 16.7K cites"] P1["The Occurrence of Sleep-Disorder...
1993 · 10.2K cites"] P2["Sleep–Related Breathing Disorder...
1999 · 5.1K cites"] P3["Prospective Study of the Associa...
2000 · 4.9K cites"] P4["Long-term cardiovascular outcome...
2005 · 4.6K cites"] P5["The American Academy of Sleep Me...
2007 · 6.6K cites"] P6["Rules for Scoring Respiratory Ev...
2012 · 5.0K cites"] P0 --> P1 P1 --> P2 P2 --> P3 P3 --> P4 P4 --> P5 P5 --> P6 style P0 fill:#DC5238,stroke:#c4452e,stroke-width:2px
Scroll to zoom • Drag to pan

Most-cited paper highlighted in red. Papers ordered chronologically.

Advanced Directions

Recent preprints explore integrated sensor systems for home PSG alternatives and PPG-based detection via ApSense on GitHub. News highlights Apnimed's pill trial in 646 patients, Mosanna's nasal spray with $80M funding, and Mount Sinai's $3.32M AI grant. UCSD trials test CPAP versus eszopiclone/oxygen, and studies link untreated OSA to Parkinson's risk.

Papers at a Glance

In the News

Code & Tools

Recent Preprints

Latest Developments

Recent developments in obstructive sleep apnea (OSA) research include the approval of the first medication, Zepbound (tirzepatide), in December 2024 for treating moderate to severe OSA in obese patients, which has shown promising results in reducing breathing disruptions (NEJM, Science, published in 2025). Additionally, innovative therapies such as hypoglossal nerve stimulation, anti-obesity pharmacotherapy, and neuromodulation techniques are being actively researched, with recent studies emphasizing precision medicine approaches (PMC, 2025).

Frequently Asked Questions

What is the Epworth Sleepiness Scale?

The Epworth Sleepiness Scale (ESS) is a self-administered questionnaire developed by Murray W. Johns (1991) to measure general daytime sleepiness in adults. One hundred and eighty adults, including 30 normals, completed it, demonstrating its utility in assessing sleepiness levels. "A New Method for Measuring Daytime Sleepiness: The Epworth Sleepiness Scale" (1991) validated its simplicity and effectiveness.

How prevalent is sleep-disordered breathing?

Terry Young et al. (1993) found high prevalence of undiagnosed sleep-disordered breathing among middle-aged men and higher than expected in women, associated with daytime hypersomnolence. P. E. Peppard et al. (2013) updated estimates due to obesity trends, confirming increased prevalence. "The Occurrence of Sleep-Disordered Breathing among Middle-Aged Adults" (1993) reported rates much higher than previously suspected.

What are the standards for scoring sleep apnea events?

The AASM Manual by Conrad Iber et al. (2007) provides rules, terminology, and specifications for scoring sleep and associated events. Richard B. Berry et al. (2012) updated these rules for respiratory events in sleep. "Rules for Scoring Respiratory Events in Sleep: Update of the 2007 AASM Manual for the Scoring of Sleep and Associated Events" (2012) refined clinical research techniques.

How does sleep apnea relate to hypertension?

Paul E. Peppard et al. (2000) identified a dose-response link between baseline sleep-disordered breathing and hypertension four years later, independent of confounders. This positions sleep-disordered breathing as a risk factor for hypertension. "Prospective Study of the Association between Sleep-Disordered Breathing and Hypertension" (2000) supports targeted interventions.

What is the global burden of obstructive sleep apnea?

Adam Benjafield et al. (2019) estimated global prevalence and burden through literature analysis. Terry Young et al. (2002) detailed epidemiology, noting high undiagnosed rates and morbidity even in mild cases. "Estimation of the global prevalence and burden of obstructive sleep apnoea: a literature-based analysis" (2019) quantifies impacts worldwide.

Open Research Questions

  • ? How do novel therapies like oral pills and nasal sprays compare to CPAP in reducing cardiovascular risks?
  • ? Can AI-based tools and wearable sensors accurately diagnose OSA outside polysomnography settings?
  • ? What subtypes of OSA symptoms exist, and how do they influence treatment responses?
  • ? Does treating OSA with CPAP lower Parkinson's disease risk, and what mechanisms are involved?
  • ? How does respiratory effort burden from mandibular movements predict OSA severity?

Research Obstructive Sleep Apnea Research with AI

PapersFlow provides specialized AI tools for your field researchers. Here are the most relevant for this topic:

Start Researching Obstructive Sleep Apnea Research with AI

Search 474M+ papers, run AI-powered literature reviews, and write with integrated citations — all in one workspace.